Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ASCO Direct Highlights Miami Symposium 2019 /
Evaluating treatment options for acute myeloid leukaemia

12th - 13th Jul 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.07.19
Views: 1272
Rating:

Dr Amanda Brahim - Memorial Healthcare System, Hollywood, FL, USA

Dr Amanda Brahim speaks to ecancer at the 2019 ASCO Direct Highlights Symposium in Miami about shifting treatment options for acute myeloid leukaemia (AML).

She explains that the panel session looked at case studies and discussed which treatment option the panel members would use.

Dr Brahim comments that the panel tried to address questions that have arisen from recent breakthroughs in available targetable agents - although they do not yet have all the answers.
 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation